z-logo
open-access-imgOpen Access
Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab
Author(s) -
L. Valor,
Georg Schett,
Bernhard Manger
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/m9dexe
Subject(s) - medicine , belimumab , dermatology , refractory (planetary science) , vasculitis , connective tissue disease , systemic disease , lupus erythematosus , immunopathology , immunology , autoimmune disease , antibody , disease , b cell activating factor , physics , b cell , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom